| PM | after death (Lat. post mortem); after noon [Lat. post meridiem]; mean pressure; pacemaker; pantomogr... |
|---|---|
| IGD | idiopathic growth hormone deficiency; interglobal distance; isolated gonadotropin deficiency |
| MCD | magnetic circular dichroism; mast-cell degranulation; mean cell diameter; mean of consecutive differ... |
| DASD | Direct Access Storage Device = RAM |
| CESD | cholesterol ester storage disease |
| storage disease | <disease> Another name for lysosomal diseases. (18 Nov 1997) |
|---|---|
| storage granule | 1. <cell biology> Membrane bounded vesicles containing condensed secretory materials (often in an inactive, zymogen, form). Otherwise known as zymogen granules or condensing vacuoles. 2. Granules found in plastids or in cytoplasm, assumed to be food reserves, often of glycogen or other carbohydrate polymer. (18 Nov 1997) |
| storage protein deamidase | <enzyme> Deamidates glutaminyl residues; isolated from germinating wheat grains Registry number: EC 3.5.1.- Synonym: seed storage protein deamidase (26 Jun 1999) |
| neutral lipid storage disease | <syndrome> Congenital ichthyosis, leukocyte vacuoles, and variable involvement of other organ systems. Synonym: neutral lipid storage disease. (05 Mar 2000) |
| disease, lipid storage | A series of disorders due to inborn errors in lipid metabolism resulting in the abnormal accumulation of lipids in the wrong places (Examples include Gaucher, Fabry and Niemann-Pick diseases and metachromatic leukodystrophy). (12 Dec 1998) |
| disease, phytanic acid storage | A genetic disorder of the fatty acid phytanic acid which accumulates and causes a number of progressive problems including polyneuritis (inflammation of numerous nerves), diminishing vision (due to retinitis pigmentosa), and wobbliness (ataxia) caused by damage to the cerebellar portion of the brain (cerebellar ataxia).(refsum's disease) (12 Dec 1998) |
| information storage and retrieval | A branch of computer or library science relating to the storage, locating, searching, and selecting, upon demand, relevant data on a given subject. (12 Dec 1998) |
| iron-storage disease | The storage of excess iron in the parenchyma of many organs, as in idiopathic haemochromatosis or transfusion haemosiderosis. (05 Mar 2000) |
| iron-storage protein | <chemical> Soluble iron storage protein from e coli; different from ferritin and haemosiderin (05 Dec 1998) |
| optical storage devices | A computer disk read by a laser beam, containing data prerecorded by a vendor. The buyer cannot enter or modify data in any way but the advantages lie in the speed of accessibility, relative immunity to damage, and relatively low cost of purchase. (12 Dec 1998) |
| lead storage battery | <chemistry> A battery (used in cars) in which the anode is lead, the cathode is lead coated with lead dioxide, and the electrolyte is a sulfuric acid solution. (09 Jan 1998) |
| lipid storage diseases | A series of disorders due to inborn errors in lipid metabolism resulting in the abnormal accumulation of lipids in the wrong places (examples include gaucher, fabry and niemann-pick diseases and metachromatic leukodystrophy). (12 Dec 1998) |
| lysosomal storage diseases | Inborn errors of metabolism characterised by defects in specific lysosomal hydrolases and resulting in intracellular accumulation of unmetabolised substrates. (12 Dec 1998) |
| acquired platelet function defect | <haematology> Platelet function can be affected by a number of different disease processes including polycythaemia vera, leukaemia, myelofibrosis, renal failure, multiple myeloma and some medications (for example penicillins, salicylates, phenothiazines). Disturbed blood clotting can be manifested by: easy bruising, bleeding gums, nosebleeds, abnormal vaginal bleeding, rectal bleeding, skin rash, vomiting blood, coughing up blood or blood in the urine. A measure of bleeding time and coagulation profile will be part of the evaluation. (29 Dec 1997) |
| antigens, human platelet | Human alloantigens expressed only on platelets, specifically on platelet membrane glycoproteins. These platelet-specific antigens are immunogenic and can result in pathological reactions to transfusion therapy. (12 Dec 1998) |